Target intelligence / Profile preview

Ribosomal protein L7-like 1 pseudogene 3 (RPL7L1P3)

Target
RPL7L1P3
Molecular classification
Other (pseudogene)
01

Overview

RPL7L1 pseudogene 3 (RPL7L1P3) is a non-coding pseudogene in the human genome, designated as such by the HUGO Gene Nomenclature Committee (HGNC ID: HGNC:39486). Pseudogenes are gene sequences with high homology to known coding genes but are typically non-functional due to mutations or lack of necessary regulatory elements for expression. RPL7L1P3 shares sequence identity with RPL7L1, a ribosomal protein paralog, but does not participate in ribosomal function or other active biological processes. RPL7L1P3 does not encode a protein and is not considered a therapeutic or pharmacological target[5][1][2][7]. Most research and disease associations discussed in the literature relate to the protein-coding RPL7L1 (Ribosomal protein L7-like 1), not the RPL7L1P3 pseudogene. The pseudogene itself does not have recognized biological roles, disease associations, or therapeutic relevance. The functional RPL7L1 protein (not RPL7L1P3) is implicated in ribosomal assembly and, according to recent pan-cancer analyses, may function as a biomarker or prognostic indicator for multiple cancers[4][3]. Findings about RPL7L1 do not apply to RPL7L1P3, except by potential confusion or misannotation.

Other names
RPL7L1P3Ribosomal protein L7-like 1 pseudogene 31500016H10Rik
02

Mechanism of action

None; no drugs target this pseudogene.

03

Biological functions

None well-established; pseudogenes do not generally fulfill active biological functions.
04

Disease associations

None; unlike the functional RPL7L1, this pseudogene is not linked directly to diseases or functional studies.
05

Safety considerations

None; not relevant for a non-coding pseudogene.
06

Interacting drugs

None reported; pseudogenes do not have known drug interactions.
07

Biomarkers

None specifically established; RPL7L1P3 is not cited as a clinical biomarker.

Beyond the preview

Go deeper on Ribosomal protein L7-like 1 pseudogene 3 (RPL7L1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7-like 1 pseudogene 3 (RPL7L1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call